cholestyramine resin has been researched along with mobiflex in 2 studies
| Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (mobiflex) | Trials (mobiflex) | Recent Studies (post-2010) (mobiflex) |
|---|---|---|---|---|---|
| 2,669 | 342 | 190 | 519 | 207 | 87 |
| Protein | Taxonomy | cholestyramine resin (IC50) | mobiflex (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 1.14 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Defoin, R; Guentert, TW; Mosberg, H | 1 |
| Defoin, R; Guentert, TW; Schmitt, M | 1 |
1 trial(s) available for cholestyramine resin and mobiflex
| Article | Year |
|---|---|
The influence of cholestyramine on the elimination of tenoxicam and piroxicam.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cholestyramine Resin; Half-Life; Humans; Male; Piroxicam; Random Allocation | 1988 |
1 other study(ies) available for cholestyramine resin and mobiflex
| Article | Year |
|---|---|
Acceleration of the elimination of tenoxicam by cholestyramine in the dog.
Topics: Administration, Oral; Animals; Charcoal; Cholestyramine Resin; Dogs; Half-Life; Injections, Intravenous; Male; Mathematics; Metabolic Clearance Rate; Piroxicam; Thiazines | 1986 |